Literature DB >> 17316166

Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangers.

Salvador Harguindey1, Stephan J Reshkin, Gorka Orive, Jose Luis Arranz, Eduardo Anitua.   

Abstract

Abnormalities in the intricate intracellular signalling pathways play a key role in the deregulation of either spontaneous (normal or pathological) or induced (therapeutic) cell death mechanisms. Some of these pathways are increasingly becoming molecular therapeutic targets in different processes, ranging from neurodegenerative diseases to cancer. Recent discoveries in research and treatment have shown that failure to induce selective cell apoptosis in hyperproliferative processes, like neoplastic diseases, and the failure to prevent spontaneous cell death in neurodegenerative diseases (HNDDs) such as Alzheimer's disease (AD), multiple sclerosis (MS), amyothrophic lateral sclerosis (ALS), Huntington's disease (HD), and retinitis pigmentosa (RP), can be interpreted as problems stemming from the same basic mechanisms but moving in diametrically opposed directions. The integrated approach advanced here represents an interdisciplinary attempt to stimulate an integrated vision of two otherwise widely separated areas of research, experimental neurology and oncology. This kind of approach to the prevention of apoptosis (therapeutic antiapoptosis) and/or other forms of cell death in HNNDs, as well as to resistance to therapeutic apoptosis in cancer (pathological antiapoptosis), has the scope to improve the understanding of the dualistic nature of the basic abnormalities underlying the pathological deregulation of cell death. In this context, an intracellular pH (pH(i))-related approach to these opposed situations is advanced to provide a unified theory of the apoptosis-antiapoptosis machinery. Some potential therapeutic possibilities opened by these lines of research, regarding the utilization of human growth factors and/or cellular anti-acidification measures directed to sustain cellular acid-base homeostasis in different HNNDs are considered because of their potential therapeutic benefit. Finally, we advance some possible dangers and side-effects raised by these very same treatment efforts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17316166     DOI: 10.2174/156720507779939841

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  23 in total

1.  Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification.

Authors:  Nelson B Cole; Diane Dieuliis; Paul Leo; Drake C Mitchell; Robert L Nussbaum
Journal:  Exp Cell Res       Date:  2008-03-28       Impact factor: 3.905

2.  An acidic residue buried in the dimer interface of isocitrate dehydrogenase 1 (IDH1) helps regulate catalysis and pH sensitivity.

Authors:  Lucas A Luna; Zachary Lesecq; Katharine A White; An Hoang; David A Scott; Olga Zagnitko; Andrey A Bobkov; Diane L Barber; Jamie M Schiffer; Daniel G Isom; Christal D Sohl
Journal:  Biochem J       Date:  2020-08-28       Impact factor: 3.857

3.  Potential involvement of intracellular pH in a mouse model of amyotrophic lateral sclerosis.

Authors:  Su-Wei Kuo; Mingchen Jiang; Cj Heckman
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-11-12       Impact factor: 4.092

Review 4.  Considering protonation as a posttranslational modification regulating protein structure and function.

Authors:  André Schönichen; Bradley A Webb; Matthew P Jacobson; Diane L Barber
Journal:  Annu Rev Biophys       Date:  2013-02-28       Impact factor: 12.981

5.  A Histidine Cluster in the Cytoplasmic Domain of the Na-H Exchanger NHE1 Confers pH-sensitive Phospholipid Binding and Regulates Transporter Activity.

Authors:  Bradley A Webb; Katharine A White; Bree K Grillo-Hill; André Schönichen; Changhoon Choi; Diane L Barber
Journal:  J Biol Chem       Date:  2016-09-20       Impact factor: 5.157

Review 6.  Cell fate decisions: emerging roles for metabolic signals and cell morphology.

Authors:  Sumitra Tatapudy; Francesca Aloisio; Diane Barber; Todd Nystul
Journal:  EMBO Rep       Date:  2017-11-20       Impact factor: 8.807

7.  Structural characterization of alpha-synuclein in an aggregation prone state.

Authors:  Min-Kyu Cho; Gabrielle Nodet; Hai-Young Kim; Malene R Jensen; Pau Bernado; Claudio O Fernandez; Stefan Becker; Martin Blackledge; Markus Zweckstetter
Journal:  Protein Sci       Date:  2009-09       Impact factor: 6.725

Review 8.  Reimagining dots and dashes: Visualizing structure and function of organelles for high-content imaging analysis.

Authors:  Marcus Y Chin; Jether Amos Espinosa; Grace Pohan; Sarine Markossian; Michelle R Arkin
Journal:  Cell Chem Biol       Date:  2021-02-17       Impact factor: 8.116

9.  Inactivation of CDK/pRb pathway normalizes survival pattern of lymphoblasts expressing the FTLD-progranulin mutation c.709-1G>A.

Authors:  Carolina Alquezar; Noemí Esteras; Ainhoa Alzualde; Fermín Moreno; Matilde S Ayuso; Adolfo López de Munain; Ángeles Martín-Requero
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

10.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.